Cabergoline
Cabergoline is a prescription medication available as 0.5 mg oral tablets, used to treat conditions like high prolactin levels or Parkinson's disease. It's a generic drug approved under ANDA076310 by Strides Pharma and marketed by various manufacturers. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| contactPoint |
{
"fn": "U.S. Food and Drug Administration (FDA)",
"@type": "vcard:Contact",
"hasEmail": "mailto:no-reply@healthdata.gov"
}
|
| description | Cabergoline is a prescription medication available as 0.5 mg oral tablets, used to treat conditions like high prolactin levels or Parkinson's disease. It's a generic drug approved under ANDA076310 by Strides Pharma and marketed by various manufacturers. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Cabergoline",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Cabergoline — ANDA 203308 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203308"
}
]
|
| identifier | https://healthdata.gov/api/views/fdfu-et76 |
| issued | 2025-11-24 |
| keyword |
[
"drug-manufacturers",
"health-care",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://healthdata.gov/d/fdfu-et76 |
| modified | 2025-11-27 |
| publisher |
{
"name": "healthdata.gov",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Cabergoline |
